The US Food and Drug Administration's (FDA) decision not to approve midomafetamine-assisted therapy (MDMA-AT) for ...

Federal health officials have declined to approve the psychedelic drug MDMA as a therapy for PTSD. Drugmaker Lykos ...

Lykos Therapeutics filed an application for FDA approval of its version of MDMA-assisted therapy for PTSD in February 2024.

The Food and Drug Administration declined Friday to approve an application to treat post-traumatic stress disorder using the ...

then FDA approval of psychedelics may be a matter of “when” not “if.” MAPS Executive Director Rick Doblin has been working to legalize MDMA for PTSD since the 1980's as ... [+] well as ...

In a previous blog on the use of psychedelics to treat mental health disorders, we reported that the US Food and Drug Administration (FDA) ...

It is considered to be more pleasure-inducing than other amphetamines, and for this reason, it has been a popular party drug. Some researchers call MDMA an “empathogen” or a “feeling enhancer.” PTSD ...

Critics addressed the elephant in the room during the FDA’s first public meeting on trauma since its decision to delay ...

WASHINGTON (AP) — Federal health regulators on Friday declined to approve the psychedelic drug MDMA as a therapy for PTSD, a ...